Verapamil primarily works by blocking calcium channels. Specifically, it targets L-type calcium channels found in the smooth muscle cells of blood vessels and the heart. This blockage reduces calcium influx into these cells.
Reduced calcium entry leads to decreased contraction of smooth muscle. In the context of Peyronie’s disease, this means less tension in the penile plaque, potentially promoting plaque softening and improved curvature.
Verapamil’s impact extends beyond blood vessels. It also affects the cells involved in scar tissue formation. By modulating calcium signaling, it may inhibit the production of collagen, a major component of the Peyronie’s plaque.
The exact mechanism through which verapamil influences collagen production is still under investigation. However, studies suggest it may involve impacting cellular processes like cell proliferation and differentiation.
While promising, it’s crucial to remember verapamil’s effectiveness in Peyronie’s disease varies. Individual responses differ, and its use requires careful medical supervision.
